C12N 2760/12233
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2760/12233 (Use of viral protein as therapeutic agent other than vaccine) appears on 4 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 4
- Assignees
- 4
- Inventors
- 12
- Latest grant
- 3 Sep 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 2 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
By publication year.
Recent patents
- Attenuated virus having multiple hosts3 Sep 2019US 10,400,220 B2The Research Foundation for The State University of New York
- Methods to produce bunyavirus replicon particles23 May 2017US 9,657,278 B2Stichting Dienst Landbouwkundig Onderzoek
- Antiviral rift valley fever virus peptides and methods of use31 Jan 2017US 9,556,237 B2The United States of America, as represented by the Secretary of the Army, on behalf of the U.S. Army Medical Research Institute of Infectious Diseases
- Methods to produce bunyavirus replicon particles18 Aug 2015US 9,109,199 B2Stichting Dienst Landbouwkundig Onderzoek
- Recoded arbovirus and vaccines3 Jan 2019US 2019/0002837 A1The Research Foundation for The State University of New York
- Methods to produce bunyavirus replicon particles7 Jan 2016US 2016/0002608 A1Stichting Dienst Landbouwkundig Onderzoek
- Antiviral rift valley fever virus peptides and methods of use26 Nov 2015US 2015/0337015 A1The United States of America, as represented by the Secretary of the Army, on behalf of the United
- Methods to produce bunyavirus replicon particles12 Sep 2013US 2013/0236493 A1Stichting Dienst Landbouwkundig Onderzoek
Most cited
By later US patents
- Antiviral rift valley fever virus peptides and methods of use8US 9,556,237 B2The United States of America, as represented by the Secretary of the Army, on behalf of the U.S. Army Medical Research Institute of Infectious Diseases · 2017
- Methods to produce bunyavirus replicon particles4US 9,109,199 B2Stichting Dienst Landbouwkundig Onderzoek · 2015